Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311. Cancer. 2003 Mar 15; 97(6):1471-80.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Cytarabine
Female
Genes, abl
Humans
Immunoconjugates
Infusions, Intravenous
Male
Middle Aged
Polymerase Chain Reaction
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Receptors, Antigen, T-Cell
Ricin
Treatment Outcome

authors with profiles

Richard A. Larson